Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcus Biosciences Inc.

8.80
+0.52006.28%
Pre-market: 8.41-0.3900-4.43%04:12 EDT
Volume:2.67M
Turnover:23.45M
Market Cap:931.79M
PE:-2.10
High:9.00
Open:8.60
Low:8.51
Close:8.28
Loading ...

Arcus Biosciences Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
09 May

Morgan Stanley Lowers Price Target on Arcus Biosciences to $22 From $24, Keeps Overweight Rating

MT Newswires Live
·
09 May

Truist Financial Reaffirms Their Buy Rating on Arcus Biosciences (RCUS)

TIPRANKS
·
09 May

Arcus Biosciences Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
08 May

Arcus Biosciences Is Maintained at Overweight by Wells Fargo

Dow Jones
·
07 May

Stock Track | Arcus Biosciences Plummets 8% as Wells Fargo Slashes Price Target

Stock Track
·
07 May

Arcus Biosciences Inc : Wells Fargo Cuts Target Price to $26 From $29

THOMSON REUTERS
·
07 May

Arcus Biosciences (RCUS) Gets a Buy from Barclays

TIPRANKS
·
07 May

Arcus Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Arcus Biosciences Q1 EPS $(1.14) Misses $(1.02) Estimate, Sales $28.00M Miss $36.54M Estimate

Benzinga
·
07 May

Stock Track | Arcus Biosciences Plummets 9.56% After Reporting Wider-Than-Expected Q1 Loss

Stock Track
·
07 May

Stock Track | Arcus Biosciences Plummets 9.56% as Q1 Earnings Miss Expectations

Stock Track
·
07 May

Arcus Biosciences Q1 EPS $-1.14

THOMSON REUTERS
·
07 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
06 May

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire
·
25 Apr

Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting

Business Wire
·
24 Apr

Arcus Biosciences Is Maintained at Overweight by Barclays

Dow Jones
·
23 Apr

Arcus Biosciences, Inc. : Barclays Cuts Target Price to $14 From $29

THOMSON REUTERS
·
23 Apr

Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2025 Financial Results and Pipeline Update

Business Wire
·
23 Apr

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire
·
10 Apr